Product Information
ISRADIPINE 2.5 MG CAPSULE is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $1.5006 per EA under NDC 16252053901. Its NADAC has been published 136 times since Nov 28, 2013.
Strength
2.5 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
16252053901
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ISRADIPINEApproval Type
Generic (ANDA)
FDA Application
ANDA077317On Market Since
1/5/2004
Pharmacological Classes
Price Statistics
The NADAC for ISRADIPINE 2.5 MG CAPSULE has been published 136 times since Nov 28, 2013, and over the history we have for it it has risen 60.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.5006 per EA |
|---|---|
| All-time high | $1.8070 (Jan 14, 2026) |
| All-time low | $0.9249 (Sep 17, 2014) |
| 52-week high | $1.8070 |
| 52-week low | $1.5006 |
| Median price | $0.9351 |
| Average price | $1.1067 |
| Largest weekly change | +93.8% (Dec 17, 2025) |
| Weeks tracked | 136 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ISRADIPINE 2.5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ISRADIPINE 2.5 MG CAPSULE, manufactured by Teva Pharmaceuticals USA Inc., is $1.5006 per EA (NDC 16252053901), effective Jun 24, 2026.
How has the price of ISRADIPINE 2.5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for ISRADIPINE 2.5 MG CAPSULE has risen 60.5%. It has been tracked across 136 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ISRADIPINE 2.5 MG CAPSULE?
Since Nov 28, 2013, the NADAC for ISRADIPINE 2.5 MG CAPSULE has ranged from a low of $0.9249 (Sep 17, 2014) to a high of $1.8070 (Jan 14, 2026), with a median of $0.9351 per EA.
Are there cheaper alternatives to ISRADIPINE 2.5 MG CAPSULE?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as ISRADIPINE 2.5 MG CAPSULE, but none are currently priced below it.
Who manufactures ISRADIPINE 2.5 MG CAPSULE?
ISRADIPINE 2.5 MG CAPSULE (NDC 16252053901) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification